CaGA nanozymes inhibit oxidative stress and protect mitochondrial function in ulcerative colitis therapy
Authors:
- 4 March 2025
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 196, 380-398
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82372552)
- Anhui Medical University (2021xkjT028)
- Natural Science Foundation of Anhui Province (2408085Y016)
This publication has 52 references indexed in Scilit:
- Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeuticsCarbon, 2023
- Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature reviewUnited European Gastroenterology Journal, 2022
- Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel diseaseCarbohydrate Polymers, 2022
- Biological drug and drug delivery-mediated immunotherapyActa Pharmaceutica Sinica B, 2021
- Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivationActa Pharmaceutica Sinica B, 2021
- Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a reviewMetabolic Brain Disease, 2019
- Recent formulation approaches to oral delivery of herbal medicinesJournal of Pharmaceutical Investigation, 2018
- Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in miceBiomaterials, 2017
- A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel diseaseBiomaterials, 2016
- Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticlesBiomaterials, 2015